---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-001268"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2026-01-15T23:59:59+00:00"
generated_at: "2026-05-16T10:05:50.930749+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Femasys granted 180-day extension to cure Nasdaq minimum bid price deficiency

## Summary
- Received Nasdaq deficiency notice July 16, 2025; bid price below $1.00 for 30 consecutive days.
- Granted extension to July 13, 2026 after requesting 180-day extension on Jan 12, 2026.
- Company reported stockholders' equity over $5M as of Dec 31, 2025; plans reverse stock split if needed.
- Common stock ticker FEMY remains listed on Nasdaq Capital Market during extension period.
- Non-compliance continues; risk of delisting if not cured by July 13, 2026.

## SEC filing metadata
- accession: 0001140361-26-001268
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2026-01-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036126001268/0001140361-26-001268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036126001268/ef20063173_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-001268
- JSON: https://secwatch.observer/filing/0001140361-26-001268.json
- Plain text: https://secwatch.observer/filing/0001140361-26-001268.txt

## Source-grounded claims
- claim_id: cc92f436d2e800fe2e758e7f5fb8e8578556dc43
  claim: FEMASYS INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: January 13, 2026, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to July 13, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and July 13, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement. SIGNATURE Pursuant to t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1339005/000114036126001268/0001140361-26-001268-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.